Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

On July 26, 2024, Windtree Therapeutics Entered Into A Securities Purchase Agreement With A Buyer For A Private Placement Of 1,250 Series C Convertible Preferred Shares And Warrants For Up To 267,380 Shares Of Common Stock, For About $1M In Gross Proceeds

Author: Benzinga Newsdesk | July 29, 2024 10:44am

- SEC Filing

Posted In: WINT